Français
ItalianoBond Genmab 7.25% ( US37230JAB89 ) in USD
| Issuer | Genmab | ||||
| Market price |  100.00 % ▲ |
||||
| Country |  Denmark
|
||||
| ISIN code |
 US37230JAB89 ( in USD )
|
||||
| Interest rate | 7.25% per year ( payment 2 times a year) | ||||
| Maturity | 15/12/2033 | ||||
|
Prospectus brochure in PDF format |
|||||
| Minimal amount | 200 000 USD | ||||
| Total amount | 1 000 000 000 USD | ||||
| Cusip | 37230JAB8 | ||||
| Standard & Poor's ( S&P ) rating | BB- ( Non-investment grade speculative ) | ||||
| Moody's rating | B1 ( Highly speculative ) | ||||
| Next Coupon | 15/12/2026 ( In 111 days ) | ||||
| Detailed description |
Genmab is an international biotechnology company specializing in antibody therapeutics for cancer treatment. The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAB89, pays a coupon of 7.25% per year. The coupons are paid 2 times per year and the Bond maturity is 15/12/2033 The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAB89, was rated B1 ( Highly speculative ) by Moody's credit rating agency. The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAB89, was rated BB- ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||